1,224 Shares of Intuitive Surgical, Inc. $ISRG Purchased by Canandaigua National Trust Co of Florida

Canandaigua National Trust Co of Florida acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 1,224 shares of the medical equipment provider’s stock, valued at approximately $498,000.

A number of other institutional investors have also recently made changes to their positions in ISRG. North Point Portfolio Managers Corp OH acquired a new stake in Intuitive Surgical during the 3rd quarter worth approximately $27,000. Main Street Group LTD acquired a new position in shares of Intuitive Surgical in the first quarter worth $30,000. Compass Financial Management LLC acquired a new position in shares of Intuitive Surgical in the second quarter worth $30,000. Vermillion Wealth Management Inc. raised its stake in shares of Intuitive Surgical by 58.1% in the first quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock valued at $31,000 after acquiring an additional 25 shares in the last quarter. Finally, Motiv8 Investments LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at $34,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Barclays began coverage of Intuitive Surgical with an Overweight rating, adding a new bullish view on the shares. Barclays starts coverage of Intuitive Surgical stock at Overweight
• Positive Sentiment: Citi reportedly assigned ISRG a Buy rating, reinforcing the recent improvement in sell-side sentiment. Intuitive Surgical gets a Buy from Citi
• Positive Sentiment: Intuitive Surgical’s single-port robotic platform is gaining traction, with rising procedures, utilization and system placements. Expanding clinical indications and international adoption could turn the platform into a major billion-dollar franchise and provide an additional growth engine beyond the company’s established da Vinci systems. Can ISRG’s Single-Port Platform Become the Next Billion-Dollar Franchise?
• Positive Sentiment: Recent commentary argues that the stock’s valuation multiple has fallen while the underlying growth story remains intact. A recovery in system sales, procedure volumes and recurring instruments-and-accessories revenue could support a rebound after a weak trailing year. Intuitive Surgical: The Multiple Fell, The Story Didn’t
• Neutral Sentiment: An industry outlook highlighted Intuitive Surgical alongside Globus Medical and Thermo Fisher Scientific, but provided limited company-specific detail or a clear new catalyst. Zacks Industry Outlook
• Negative Sentiment: Jim Cramer expressed less enthusiasm for ISRG, citing the growing number of competitors—particularly Johnson & Johnson—as a threat to the company’s long-term positioning. This underscores the risk that competition could pressure growth or valuation. Intuitive Surgical and JNJ Give Jim Cramer More Than Valuation to Consider

Analyst Upgrades and Downgrades

Several research analysts recently commented on ISRG shares. HSBC cut Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 target price for the company. in a research note on Thursday, July 30th. Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a research note on Friday, August 14th. Barclays began coverage on shares of Intuitive Surgical in a research note on Tuesday. They set an “overweight” rating and a $485.00 target price on the stock. TD Cowen cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Tuesday, July 28th. Finally, Leerink Partners decreased their price target on shares of Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating for the company in a research note on Friday, July 17th. Twenty-two equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $502.53.

Insider Buying and Selling

In other news, Director Gary S. Guthart sold 10,000 shares of the company’s stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $400.00, for a total value of $4,000,000.00. Following the completion of the transaction, the director owned 1,245,679 shares in the company, valued at approximately $498,271,600. This represents a 0.80% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the stock in a transaction on Monday, August 10th. The shares were sold at an average price of $379.00, for a total transaction of $151,600.00. Following the completion of the transaction, the executive vice president directly owned 5,320 shares in the company, valued at $2,016,280. This trade represents a 6.99% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 12,370 shares of company stock valued at $4,891,989 over the last three months. 0.60% of the stock is currently owned by insiders.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG traded up $9.76 on Wednesday, hitting $414.52. 1,895,998 shares of the company’s stock were exchanged, compared to its average volume of 2,423,132. Intuitive Surgical, Inc. has a 1-year low of $328.57 and a 1-year high of $603.88. The company has a market capitalization of $146.44 billion, a PE ratio of 47.48, a P/E/G ratio of 3.07 and a beta of 1.46. The firm’s 50-day moving average is $382.47 and its 200 day moving average is $412.07.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.48 by $0.32. The business had revenue of $2.89 billion for the quarter, compared to analyst estimates of $2.83 billion. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The business’s quarterly revenue was up 18.4% on a year-over-year basis. During the same quarter last year, the company earned $1.81 EPS. On average, analysts anticipate that Intuitive Surgical, Inc. will post 8.87 EPS for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company’s products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.